Skip to search formSkip to main contentSkip to account menu

Cyclophosphamide/Doxorubicin/Etoposide/Prednisone/Vincristine

Known as: Cyclophosphamide-Hydroxydaunorubicin-Oncovin-Prednisone-Etoposide Regimen, CHOPE regimen, VAC0P 
An abbreviation for a chemotherapy combination that is used to treat non-Hodgkin lymphoma. It includes the drugs cyclophosphamide, doxorubicin… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Rationale: Cytokine release syndrome (CRS) is a common and potentially fatal complication of CAR-T cell therapy. However… 
2018
2018
Rationale: T-cell lymphoma is a neoplasm that expresses markers of T-cell or natural killer cell (NK)-origin but not those of B… 
2015
2015
OBJECTIVE To analyze clinical features and outcomes of non-upper aerodigestive tract NK/T-cell lymphoma (NUAT-NKTCL). METHODS… 
2014
2014
We herein report the case of a 50-year-old woman who presented with persistent fever and a large mass in her right breast… 
2013
2013
This article charts industrial relations in BBC television from 1969-84. It is based upon extensive archival research of material… 
2011
2011
I was an undergraduate student of David Webster’s. He shared many stories about his fieldwork but never published the thesis… 
2004
2004
Drug resistance is a common phenomenon in clinical oncology. In vitro, tamoxifen has been shown to be an effective inhibitor of P… 
2000
2000
BACKGROUND Patients with resistant diffuse aggressive non-Hodgkin's lymphoma (DA-NHL) have a poor prognosis. Studies have… 
1998
1998
A research report in partial fulfilment of the requirements for the degree of Master of Science (by coursework and research…